Already registered? Need to register? Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

About the PCSK9 Education and Research Forum

PCSK9 Education and Research Forum is the independent resource on PCSK9 science and its translation into critically important new treatments to lower low density lipoprotein cholesterol (LDL-C), which promise to transform the prognosis of millions of patients with hypercholesterolaemia (cholesterol disorders), accelerated atherosclerotic vascular heart disease and a high risk of premature cardiovascular (CV) death and disability.
Aims & ObjectivesMission StatementEditorial BoardPartnership & OutreachForthcoming Meetings
Why are new treatments needed?

Why are new
treatments needed?

Read more »
What are the benefits of PCSK9 inhibitors?

What are the benefits
of PCSK9 inhibitors?

Read more »
PCSK9 inhibitors in real world practice?

PCSK9 inhibitors in
real world practice?

Read more »
Most viewed

PCSK9 inhibition at the limits

With the PCSK9 inhibitors, are we now at the limit for LDL-C lowering?

video

PCSK9 Forum Co-Editor Professor John Chapman discusses these important questions in this video.

View the video & presentation

From the Editors

Premium quality or just over-priced? How affordable are the PCSK9 monoclonal antibodies?Premium quality or just over-priced? How affordable are the PCSK9 monoclonal antibodies?Anthony Wierzbicki

Anthony Wierzbicki, Guy’s & St Thomas’ Hospitals, London discusses recent economic analyses from the US and UK.


Read the full article

Latest Videos & Congress News

AHA Scientific Sessions
12-16 November 2016

AHA Scientific Sessions
News from Late Breaking Clinical Trials: 15th Nov

Orion-1: Novel PCSK9 RNA Interference agent

GLAGOV: IVUS trial with evolocumab